Confounders in natural history of interferon-β-treated relapsing multiple sclerosis [4]

Annals of Neurology

Volumn 63, Issue 1, 2008, Pages 126-

  Gout, Olivier ^a  

^a Fondation Opthalmologique Adolphe de Rothschild ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON;

DISEASE COURSE; HUMAN; LETTER; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; RELAPSE; SENSITIVITY ANALYSIS;

CLINICAL TRIALS AS TOPIC; CONFOUNDING FACTORS (EPIDEMIOLOGY); DATA INTERPRETATION, STATISTICAL; DISEASE PROGRESSION; HUMANS; IMMUNOLOGIC FACTORS; IMMUNOTHERAPY; INTERFERON-BETA; MAGNETIC RESONANCE IMAGING; MULTIPLE SCLEROSIS; RECURRENCE; REPRODUCIBILITY OF RESULTS;

EID: 39049154445     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.21186     Document Type: Letter

References (4)

1. Trojano M, Pellegrini F, Fuiani A, et al. New natural history of interferon β-treated relapsing multiple sclerosis. Ann Neurol 2007;61:300-306.
2. Runmarker B, Andersen O. Prognostic factors in a multiple sclerosis incidence cohort with twenty-five years of follow-up. Brain 1993;116:117-134.
3. Weinshenker BG, Bass B, Rice GPA, et al. The natural history of multiple sclerosis: a geographically based study. 2. Predictive value of the early clinical course. Brain 1989;112:1419-1428.
4. Confavreux C, Vukusic S, Adeleine P. Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process. Brain 2003;126:770-782.